ChemoCentryx, Inc. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ChemoCentryx, Inc. for January 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Option Exercise | M | 0.00 | 13,333 | 0 | 26,667 | |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Payment of Exercise | F | 7.40 | 7,088 | 52,451 | 59,839 | 66.9 K to 59.8 K (-10.59 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | Chief Medical Offic ... | Buy | M | 0.00 | 13,333 | 0 | 66,927 | 53.6 K to 66.9 K (+24.88 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 26,821 | 115,330 | 0 | |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 8,333 | 0 | 16,667 | |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 7.51 | 26,821 | 201,305 | 16,391 | 43.2 K to 16.4 K (-62.07 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 26,821 | 115,330 | 43,212 | 16.4 K to 43.2 K (+163.63 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Payment of Exercise | F | 7.40 | 4,442 | 32,871 | 16,391 | 20.8 K to 16.4 K (-21.32 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 8,333 | 0 | 20,833 | 12.5 K to 20.8 K (+66.66 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 20,000 | 0 | 40,000 | |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 7.40 | 10,723 | 79,350 | 9,277 | 20 K to 9.3 K (-53.61 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,333 | 0 | 66,667 | |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 7.40 | 17,955 | 132,867 | 2,155,045 | 2.2 M to 2.2 M (-0.83 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,333 | 0 | 2,173,000 | 2.1 M to 2.2 M (+1.56 %) |